484 related articles for article (PubMed ID: 37894774)
1. The Role of Short-Chain Fatty Acids in Microbiota-Gut-Brain Cross-Talk with a Focus on Amyotrophic Lateral Sclerosis: A Systematic Review.
Moțățăianu A; Șerban G; Andone S
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894774
[TBL] [Abstract][Full Text] [Related]
2. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases.
Spielman LJ; Gibson DL; Klegeris A
Neurochem Int; 2018 Nov; 120():149-163. PubMed ID: 30114473
[TBL] [Abstract][Full Text] [Related]
3. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health.
Nogal A; Valdes AM; Menni C
Gut Microbes; 2021; 13(1):1-24. PubMed ID: 33764858
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota alterations and dietary modulation in childhood malnutrition - The role of short chain fatty acids.
Pekmez CT; Dragsted LO; Brahe LK
Clin Nutr; 2019 Apr; 38(2):615-630. PubMed ID: 29496274
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of short-chain fatty acid production by gut microbiota in neurodegenerative disorders.
Yadav S; Dwivedi A; Tripathi A; Tripathi AK
Nutr Res; 2022 Oct; 106():72-84. PubMed ID: 36152586
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling.
Sajdel-Sulkowska EM
Biomed Res Int; 2021; 2021():7880448. PubMed ID: 34651049
[TBL] [Abstract][Full Text] [Related]
7. The microbiota-gut-brain axis participates in chronic cerebral hypoperfusion by disrupting the metabolism of short-chain fatty acids.
Xiao W; Su J; Gao X; Yang H; Weng R; Ni W; Gu Y
Microbiome; 2022 Apr; 10(1):62. PubMed ID: 35430804
[TBL] [Abstract][Full Text] [Related]
8. Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis.
Calvo AC; Valledor-Martín I; Moreno-Martínez L; Toivonen JM; Osta R
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627250
[TBL] [Abstract][Full Text] [Related]
9. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism.
Morrison DJ; Preston T
Gut Microbes; 2016 May; 7(3):189-200. PubMed ID: 26963409
[TBL] [Abstract][Full Text] [Related]
10. Diabesity and mood disorders: Multiple links through the microbiota-gut-brain axis.
Farzi A; Hassan AM; Zenz G; Holzer P
Mol Aspects Med; 2019 Apr; 66():80-93. PubMed ID: 30513310
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiota-Derived Short-Chain Fatty Acids Facilitate Microbiota:Host Cross talk and Modulate Obesity and Hypertension.
Overby HB; Ferguson JF
Curr Hypertens Rep; 2021 Feb; 23(2):8. PubMed ID: 33537923
[TBL] [Abstract][Full Text] [Related]
12. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders.
Chandra S; Alam MT; Dey J; Sasidharan BCP; Ray U; Srivastava AK; Gandhi S; Tripathi PP
Curr Top Med Chem; 2020; 20(13):1142-1153. PubMed ID: 32282304
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota and energy balance: role in obesity.
Blaut M
Proc Nutr Soc; 2015 Aug; 74(3):227-34. PubMed ID: 25518735
[TBL] [Abstract][Full Text] [Related]
14. Brain-Gut-Microbiota Axis in Amyotrophic Lateral Sclerosis: A Historical Overview and Future Directions.
Chen S; Cai X; Lao L; Wang Y; Su H; Sun H
Aging Dis; 2024 Feb; 15(1):74-95. PubMed ID: 37307822
[TBL] [Abstract][Full Text] [Related]
15. Short-chain fatty acids as a link between diet and cardiometabolic risk: a narrative review.
Birkeland E; Gharagozlian S; Valeur J; Aas AM
Lipids Health Dis; 2023 Mar; 22(1):40. PubMed ID: 36915164
[TBL] [Abstract][Full Text] [Related]
16. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.
Westfall S; Lomis N; Kahouli I; Dia SY; Singh SP; Prakash S
Cell Mol Life Sci; 2017 Oct; 74(20):3769-3787. PubMed ID: 28643167
[TBL] [Abstract][Full Text] [Related]
17. Role of microbiota-derived short-chain fatty acids in nervous system disorders.
Mirzaei R; Bouzari B; Hosseini-Fard SR; Mazaheri M; Ahmadyousefi Y; Abdi M; Jalalifar S; Karimitabar Z; Teimoori A; Keyvani H; Zamani F; Yousefimashouf R; Karampoor S
Biomed Pharmacother; 2021 Jul; 139():111661. PubMed ID: 34243604
[TBL] [Abstract][Full Text] [Related]
18. Gut-Modulating Agents and Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives.
Noor Eddin A; Alfuwais M; Noor Eddin R; Alkattan K; Yaqinuddin A
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474719
[TBL] [Abstract][Full Text] [Related]
19. The Gut-Brain Axis in Schizophrenia: The Implications of the Gut Microbiome and SCFA Production.
Ju S; Shin Y; Han S; Kwon J; Choi TG; Kang I; Kim SS
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892465
[TBL] [Abstract][Full Text] [Related]
20. A Gut Feeling in Amyotrophic Lateral Sclerosis: Microbiome of Mice and Men.
Martin S; Battistini C; Sun J
Front Cell Infect Microbiol; 2022; 12():839526. PubMed ID: 35360111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
